» Articles » PMID: 29062072

Development and Regulation of Single- and Multi-species Candida Albicans Biofilms

Overview
Date 2017 Oct 25
PMID 29062072
Citations 244
Authors
Affiliations
Soon will be listed here.
Abstract

Candida albicans is among the most prevalent fungal species of the human microbiota and asymptomatically colonizes healthy individuals. However, it is also an opportunistic pathogen that can cause severe, and often fatal, bloodstream infections. The medical impact of C. albicans typically depends on its ability to form biofilms, which are closely packed communities of cells that attach to surfaces, such as tissues and implanted medical devices. In this Review, we provide an overview of the processes involved in the formation of C. albicans biofilms and discuss the core transcriptional network that regulates biofilm development. We also consider some of the advantages that biofilms provide to C. albicans in comparison with planktonic growth and explore polymicrobial biofilms that are formed by C. albicans and certain bacterial species.

Citing Articles

V-ATPase contributes to the cariogenicity of Candida albicans- Streptococcus mutans biofilm.

Jiang Q, Xu M, Chen H, Zhang Y, Sun Y, Tao L NPJ Biofilms Microbiomes. 2025; 11(1):41.

PMID: 40057552 PMC: 11890576. DOI: 10.1038/s41522-025-00660-7.


Polymicrobial interactions of and its role in the process of oral diseases.

Fan Y, Chen X, Shan T, Wang N, Han Q, Ren B J Oral Microbiol. 2025; 17(1):2469896.

PMID: 40013013 PMC: 11864007. DOI: 10.1080/20002297.2025.2469896.


Fungal biofilms in human health and disease.

Ramage G, Kean R, Rautemaa-Richardson R, Williams C, Lopez-Ribot J Nat Rev Microbiol. 2025; .

PMID: 39910237 DOI: 10.1038/s41579-025-01147-0.


Who arrived first? Priority effects on Candida albicans and Pseudomonas aeruginosa dual biofilms.

Arevalo-Jaimes B, Admella J, Torrents E Commun Biol. 2025; 8(1):160.

PMID: 39901054 PMC: 11790929. DOI: 10.1038/s42003-025-07609-8.


Innovative antifungal strategies: enhanced biofilm inhibition of by a modified tea tree oil formulation.

Tuan D, Uyen P, Khuon N, Binh L, Masak J Front Microbiol. 2025; 15:1518598.

PMID: 39881994 PMC: 11778174. DOI: 10.3389/fmicb.2024.1518598.


References
1.
Harriott M, Noverr M . Ability of Candida albicans mutants to induce Staphylococcus aureus vancomycin resistance during polymicrobial biofilm formation. Antimicrob Agents Chemother. 2010; 54(9):3746-55. PMC: 2934986. DOI: 10.1128/AAC.00573-10. View

2.
Rajendran R, May A, Sherry L, Kean R, Williams C, Jones B . Integrating Candida albicans metabolism with biofilm heterogeneity by transcriptome mapping. Sci Rep. 2016; 6:35436. PMC: 5073228. DOI: 10.1038/srep35436. View

3.
Sudbery P . Growth of Candida albicans hyphae. Nat Rev Microbiol. 2011; 9(10):737-48. DOI: 10.1038/nrmicro2636. View

4.
Finkel J, Xu W, Huang D, Hill E, Desai J, Woolford C . Portrait of Candida albicans adherence regulators. PLoS Pathog. 2012; 8(2):e1002525. PMC: 3280983. DOI: 10.1371/journal.ppat.1002525. View

5.
Hogan D, Kolter R . Pseudomonas-Candida interactions: an ecological role for virulence factors. Science. 2002; 296(5576):2229-32. DOI: 10.1126/science.1070784. View